Vertaling van "quarter with excellent " (Nederlands → Frans) :

Double-digit growth in the second quarter with excellent contributions from all divisions
Croissance à deux chiffres au deuxième trimestre grâce à d’importantes contributions de toutes les divisions

Basel, October 21, 2010 — Commenting on the results, Joseph Jimenez, CEO of Novartis, said: “I am pleased with our excellent performance in the third quarter.
Bâle, le 21 octobre 2010 – En commentant les résultats, Joseph Jimenez, Directeur général de Novartis, a déclaré: «Je suis satisfait de notre excellente performance au troisième trimestre.

Fourth quarter Dynamic results from Pharmaceuticals and Vaccines and Diagnostics secured the Group’s excellent performance, with net sales growth of 1% (+8% lc) reflecting the severe negative impact of volatile currency markets.
Quatrième trimestre Les résultats dynamiques de Pharmaceuticals ainsi que de Vaccins et Diagnostic ont assuré l’excellente performance du Groupe alors que la progression de 1% (+8% en m. l) reflète l’effet extrêmement négatif de la volatilité des marchés des devises.

31-okt-2013 Bayer continues positive business momentum Ongoing dynamic trend in Life Sciences; MaterialScience level with prior-year quarter / New pharmaceutical products post excellent growth / Group sales EUR 9,643 million (minus 0.2 percent; Fx & portfolio adj. plus 6.0 percent) / EBIT shows 47.5 percent improvement to EUR 1,221 million / EBITDA before special items moves 7.7 percent higher to EUR 1,984 million / Net income advances by 42.1 percent to EUR 733 million / Core earnings per share up 8.5 percent to EUR 1.27 / Group guidance for 2013 maintained » meer
31-oct.-2013 Bayer continues positive business momentum Ongoing dynamic trend in Life Sciences; MaterialScience level with prior-year quarter / New pharmaceutical products post excellent growth / Group sales EUR 9,643 million (minus 0.2 percent; Fx & portfolio adj. plus 6.0 percent) / EBIT shows 47.5 percent improvement to EUR 1,221 million / EBITDA before special items moves 7.7 percent higher to EUR 1,984 million / Net income advances by 42.1 percent to EUR 733 million / Core earnings per share up 8.5 percent to EUR 1.27 / Group guidance for 2013 maintained » En savoir plus